Q. Mavacamten was recently assessed and found to be useful in which of the following disease?
A. DCMP
B. HOCM
C. Coronary artery disease with mitral regurgitation
D. Amyloidosis
Answer: B. HOCM
Mavacamten is a medication that relaxes the heart muscle and treats obstructive hypertrophic cardiomyopathy (HCM). It is a small-molecule inhibitor of cardiac myosin that reduces myocardial contractility and improves myocardial energetics.
This comment has been removed by the author.
ReplyDelete